Boris I. Chobrutskiy

Recovery of T-cell receptor V(D)J recombination reads from lower grade glioma exome files correlates with reduced survival and advanced cancer grade

Boris I. Chobrutskiy, Saif Zaman, Wei Lue Tong et al. · Journal of Neuro-Oncology · 2018 · 61 citations

Neuro-oncology, Glioma, Immunology +7

High-throughput, sliding-window algorithm for assessing chemical complementarity between immune receptor CDR3 domains and cancer mutant peptides: TRG-PIK3CA interactions and breast cancer

Boris I. Chobrutskiy, Andrea Chobrutskiy, Saif Zaman et al. · Molecular Immunology · 2021 · 37 citations

Cancer Mutant Peptides, Sliding-window Algorithm, Engineering +10

T-cell receptor-α CDR3 domain chemical features correlate with survival rates in bladder cancer

Boris I. Chobrutskiy, Saif Zaman, Andrea Diviney et al. · Journal of Cancer Research and Clinical Oncology · 2018 · 36 citations · Full text

Cancer Immunosurveillance, Genitourinary Cancer, Survival Rates +10

Chemical complementarity between immune receptor CDR3s and IDH1 mutants correlates with increased survival for lower grade glioma

Boris I. Chobrutskiy, Michelle Yeagley, Price Tipping et al. · Oncogene · 2019 · 33 citations

Cancer Immunosurveillance, Immunology, Idh1 Mutants +9

Electrostatic complementarity of B-cell receptor CDR3s and TP53-mutant amino acids in breast cancer is associated with increased disease-free survival rates

Juan F. Arturo, Boris I. Chobrutskiy, Michelle Yeagley et al. · Cellular and Molecular Immunology · 2019 · 31 citations · Full text

Breast Oncology, Tp53-mutant Amino Acids, Immunology +7